Neurol. praxi. 2009;10(5):280-284

Evaluation of cerebrospinal fluid - current potentials

MUDr. Ondřej Sobek, CSc1, doc. MUDr. Pavel Adam, CSc1, RNDr. Ing. Petr Kelbich2, MUDr. Martina Koudelková1, MUDr. David Doležil Ph.D3, MUDr. Jiří Kasík, Ph.D4, MUDr. Lenka Hajduková4, Mgr. Martin Krušina2, MUDr. Martina Hybeľová1
1 Laboratoř pro likvorologii a neuroimunologii - Toplex, s.r.o., expertní pracoviště SEKK, ÚVN Praha
2 Oddělení klinické biochemie, hematologie a imunologie Nemocnice Kadaň s.r.o., Kadaň
3 Neurologická klinika FNsP Ostrava-Poruba
4 Neurologické oddělení ÚVN, Praha

In this review article, general information is expressed concerning available biochemical, cytological, ammunological and microbiological

metodologies of cerebrospinal fluid evaluation. Basic and advanced criteria of investigation are distiguished, including advanced parameters

of CSF. Basic algorithm of laboratory evaluation of CSF is recommended, in association with concrete neurological diagnosis.

Keywords: cerebrospinal fluid, cytology, proteins, neuroimmunology, microbiological evaluation.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sobek O, Adam P, Kelbich P, Koudelková M, Doležil D, Kasík J, et al.. Evaluation of cerebrospinal fluid - current potentials. Neurol. praxi. 2009;10(5):280-284.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adam P, Sobek O, Táborský L. Orosomucoid (alpha1-glykoprotein) Levels in MS Patients Subgroups. Clinica Chimica Acta 2003; 334(1-2): 107-110. Go to original source... Go to PubMed...
    2. Adam P, Táborský L, Průcha M, Sobek O, Kratochvíla J, Zeman D: Cerebrospinal Fluid Cytology. A Monograph. Medica News Publishers, Prague 2000.
    3. Adam P, Táborský L, Sobek O, Hildebrand T, Kelbich P, Průcha M, Hyánek J. Cerebrospinal Fluid. Advances in Clinical Chemistry 2001; 36: 1-62. Go to original source... Go to PubMed...
    4. Aurelius E, Johansson B, Sköldenberg B, Staland A, Forsgren M. Department Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet. 1991 Jan 26; 337(8735): 189-192. Go to original source... Go to PubMed...
    5. Bednářová J, Štourač P, Adam P. The diagnostical relevance of immunological variables in neuroborreliosis and multiple sclerosis. Acta Neurologica Scandinavica 2005; 112: 97-102. Go to original source... Go to PubMed...
    6. Deisenhammer F, Bartoš A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F. Guidelines on routine cerebrospinal fluid analysis. Report from EFNS task force. European Journal of Neurology 2006; 13: 913-922. Go to original source... Go to PubMed...
    7. Doležil D, Štourač P, Hromada J. Paraneoplastické syndromy postihující centrální a periferní nervový systém. Trendy v medicíně 2000; 2: 57-61.
    8. Felgenhauer K. Laboratory diagnosis of neurological diseases Laboratory diagnosis of neurological dideases, pp. 1317-1327. In: Thomas L: Clinical Laobratory Diagnostics. A Monograph. TH-Books, Frankfurt/Main1998.
    9. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Öhman S, Racke MK, Sharief M, Sindic CJM, Sellebjerg F, Tourtellotte WW: Recommended stndard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. A Concensus Statement. Archives of Neurology 2005; 62: 865-870. Go to original source... Go to PubMed...
    10. Hořejší V, Bartůňková J. Základy imunologie. Triton, Praha 2005.
    11. Kelbich P, Koudelková M, Machová H, Tomaškovič M, Vachata P, Kotalíková P, Chmelíková V, Hanuljaková E: Význam urgentního vyšetření CSF pro včasnou diagnostiku neuroinfekcí. Klinická mikrobiologie a infekční lékařství 2007; 13: 9-20. Go to PubMed...
    12. Kleine TO, Damm T, Althaus H. Quantification of ?-trace protein and detection of transferrin isoforms in mixtures of cerebrospinal fluid and blood serum as models of rhinorrhea and otorrhea diagnosis. Journal of Analytical Chemistry 2000; 366: 382-386. Go to original source... Go to PubMed...
    13. Krejsek J, Kopecký O. Klinická imunologie. NUCLEUS, Hradec Králové 2004.
    14. Lamers KJB, Wevers RA. Cerebrospinal Fluid Diagnostics: Biochemical and Clinical Aspects. Klinická biochemie a metabolizmus 1995; 24: 63-75.
    15. Maier B, Laurer HL, Rose S, Buurman WA, Marzi I. Physiological Levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: A normative Study. Journal of Neurotrauma 2005; 22: 822-835. Go to original source... Go to PubMed...
    16. Reiber H. The hyperbolic function: a mathematical solution of the protein flux/CSF flow model for blood-CSF barrier function. Journal of Neurological Science 1994; 126: 243-245. Go to original source...
    17. Reiber H, Thompson EJ, Grimsley G, Bernardi G, Adam P, Monteiro de Almeida S, Freedman P, Keir G, Lammers L, Liblau R, Menna-Barreto M, Sa MJ, Seres E, Sindic CJM, Teelken A, Trendelenburg C, Trojano M, van Antwerpen M, Verbeek MM. Quality Assurance for Cerebrospinal Fluid Analysis: International Consensus by an Internet-Based Group Discussion. Clinical Chemistry and Laboratory Medicine 2003; 41: 331-337. Go to original source... Go to PubMed...
    18. Roine I, Saukkoriipi A, Leinonen M, Peltola H. LatAm Meningitis Study Group. Microbial genome count in cerebrospinal fluid compared with clinical characteristics in pneumococcal and Haemophilus influenzae type b meningitis in children. Diagnostic Mikrobiology and Infectious Diseases 2009; 63(1): 16-23. Go to original source... Go to PubMed...
    19. Sobek O, Adam P. Letter to the editors: On Seyfert S, Kunzmann V, Schwertfeger N, Koch HC, Faulstich A. Determinants of lumbar CSF protein concentration. Journal of Neurology 2003; 3(250): 371-372. Go to original source... Go to PubMed...
    20. Sobek O, Adam P, Svatoňová J. Letter to the Editor - Comments on published article by F. Deisenhammer, et al. European Journal of Neurology 2007; 14: 1468. Go to original source... Go to PubMed...
    21. Stoeck K, Bodemer M, Zerr I. Pro - and anti-inflammatory cytokines in the CSF of patients with Creutzfeld-Jocob disease. Journal of Neuroimmunology 2006; 172: 175-181. Go to original source... Go to PubMed...
    22. Štourač P. Antineuronální autoprotilátky vůči antigenům centrálního nervového systému detekované metodou Western blot a imunofluorescencí u pacientů s myasthenia gravis a Lambertovým-Eatonovým myastenickým syndromem. Klinická biochemie a metabolizmus 1998; 6(27): 207-209.
    23. Štourač P, Bednářová J. Intratekální, antivirová a oligoklonální IgG syntéza u sclerosis multiplex a její význam v diferenciální diagnostice neurologických onemocnění. Klinická biochemie a metabolizmus. 2000; 8(29): 204-208.
    24. Tavakoli NP, Wang H, Nattanmai S, Dupuis M, Fusco H, Hull R. Detection and typing of enteroviruses from CSF specimens from patients diagnosed with meningitis/encephalitis. Journal of Clinical Virolology 2008; 43(2): 207-211. Go to original source... Go to PubMed...
    25. Voltz R. Paraneoplastic neurological syndromes: An update on diagnosis, pathogenesis and therapy. The Lancet Neurology 2004; 1: 294-305. Go to original source... Go to PubMed...
    26. Zeman D, Adam P, Kalistova H, Sobek O, Andel J, Andel M. Cerebrospinal Fluid Cytological Findings in Multiple Sclerosis. A Comparison Between Patient Subgroups. Acta Cytologica 2001; 45: 51-59. Go to original source... Go to PubMed...
    27. Zeman D, Adam P, Kalistova H, Sobek O, Kelbich P, Andel J, Andel M. Transferrin in patients with multiple sclerosis: a comparison among various subgroups of multiple sclerosis patients. Acta Neurologica Scandinavica 2000; 101: 89-94. Go to original source... Go to PubMed...
    28. Zeman D, Vaníčková Z, Benáková H, Havrdová E. Volné lehké řetězce typu kappa v likvoru a séru. Klinická biochemie a metabolizmus. 2002; 10(31): 98-102.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.